Two‐dimensional shear wave elastography (2D‐SWE) has proven to be efficient for the
evaluation of liver fibrosis in small to moderate‐sized clinical trials. We aimed at running a …

Background & Aims: In hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHBe-),
interferon (IFN) achieves very low biochemical sustained response rates. No information …

Objective To evaluate the risk and predictors of hepatocellular carcinoma (HCC) in HBeAg-
negative chronic hepatitis B patients of the large HEPNET. Greece cohort study who …

Background Quantification of HBsAg in serum may be of clinical importance in predicting
HBsAg seroconversion and complete response to treatment. Methods Serum HBsAg was …

The prevalence of antithyroid peroxidase antibodies (ATPO) and/or of thyroid dysfunction
was studied in 422 patients with chronic viral hepatitis C, B, and D. Baseline results were …

Background & Aims Hepatitis D virus (HDV) has decreased in Europe, but recent reports
indicate a rising trend. We report the epidemiological changes, clinical progress, and effect …

Diabetes mellitus has been reported to have an increased prevalence and to be associated
with more severe fibrosis in patients with chronic hepatitis C. We evaluated the prevalence …

Objectives The aim of this prospective study was to examine the safety of anti-tumour
necrosis factor (TNF) therapy in patients with rheumatic disease and hepatitis B virus (HBV) …

The diagnosis of hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B indicating
therapeutic intervention currently requires serum hepatitis B virus (HBV) DNA≥ 2,000 …

Objective. Leptin and adiponectin have been implicated in the pathogenesis and
progression of non-alcoholic steatohepatitis (NASH) and chronic hepatitis C (CHC), but little …